IMTX
Immatics N.V.
NASDAQ · Healthcare · Biotechnology · DE
$9.56
+1.06%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$0.58
- Revenue estimate
- $12.6M
Latest reported
- Last report date
- Aug 18, 2026
- EPS actual
- -$0.53
- EPS estimate
- -$0.47
- Revenue actual
- $11.9M
- Revenue estimate
- $12.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.3%
- Revenue beats (12Q)
- 6
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026